Photo:
faculty.mdanderson.org
Jun 27, 2026, 13:40
Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis
Naveen Pemmaraju, Executive Director-Cancer Medicine for MDACC Cancer Network, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Expert Review of Hematology, adding:
“Pleased to share our brand new collaborative MPN paper just published in Expert Review of Hematology!”
Title: Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison
Authors: Naveen Pemmaraju, Alessandro Lucchesi, Stephen T Oh, Koo Wilson, Zalmai Hakimi, Sarah A Buckley, Purvi Suthar, Mikolaj Parkitny, Piotr Wojciechowski, Klaudia Kolonko, John O Mascarenhas
Stay updated on all scientific advances with Hemostasis Today.
Alessandro Lucchesi
Expert Review of Hematology
Health
Hematology
Hemostasis
Hemostasis News
Hemostasis Today
John O Mascarenhas
Klaudia Kolonko
Koo Wilson
Medicine
Mikolaj Parkitny
Momelotinib
MPN
Naveen Pemmaraju
Pacritinib
Piotr Wojciechowski
Purvi Suthar
Sarah A Buckley
Stephen T Oh
thrombosis
Zalmai Hakimi
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge